Synopsis
Synopsis
0
EU WC
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Akamin
2. Akne Puren
3. Akne-puren
4. Aknemin
5. Aknin Mino
6. Aknin-mino
7. Aknosan
8. Apo Minocycline
9. Apo-minocycline
10. Arestin
11. Blemix
12. Cyclomin
13. Cyclops
14. Dentomycin
15. Dynacin
16. Hydrochloride, Minocycline
17. Icht Oral
18. Icht-oral
19. Klinomycin
20. Lederderm
21. Mestacine
22. Minakne
23. Mino Wolff
24. Mino-wolff
25. Minocin
26. Minocin Mr
27. Minoclir
28. Minocycline
29. Minocycline Monohydrochloride
30. Minocycline, (4r-(4 Alpha,4a Beta,5a Beta,12a Beta))-isomer
31. Minolis
32. Minomycin
33. Minoplus
34. Minotab
35. Minox 50
36. Monohydrochloride, Minocycline
37. Mynocine
1. 13614-98-7
2. Minocycline Hcl
3. Arestin
4. Solodyn
5. Minomycin
6. Minocin
7. Dynacin
8. Periocline
9. Ximino
10. Minocycline (hydrochloride)
11. Vectrin
12. Minomax
13. (4s,4as,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hydrochloride
14. Mynocine Hydrochloride
15. Minocycline (as Hydrochloride)
16. Minocycline, Hydrochloride
17. 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
18. 0020414e5u
19. Tri-mino
20. Nsc-141993
21. Dsstox_cid_24545
22. Dsstox_rid_80306
23. Dsstox_gsid_44545
24. (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride
25. [4s-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide Monohydrochloride
26. Lederderm
27. Mynocine
28. Acnez
29. Minomycin Chloride
30. Chebi:50697
31. (4s-(4alpha,4aalpha,5aalpha,12aalpha))-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide Monohydrochloride
32. [4s-(4?,4a?,5a?,12a?)]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
33. 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, Hydrochloride (1:2), (4s,4as,5ar,12as)-
34. Einecs 237-099-7
35. Minocycline Hydrochloride (internal Use)
36. C23h27n3o7.hcl
37. Minocycline, Hcl
38. Unii-0020414e5u
39. Ncgc00096006-01
40. Prestwick_626
41. Arestin (tn)
42. Dynacin (tn)
43. Minocin (tn)
44. Solodyn (tn)
45. Minocycline Hydrochloride [usp:jan]
46. 7-dimethylamino-6-demethyl-6-deoxytetracycline, Hcl
47. Mfcd00083669
48. Minocyclinhydrochlorid
49. Amzeeq
50. Minolira
51. Zilxi
52. Minomycin Hydrochloride
53. Schembl2537
54. Cas-13614-98-7
55. 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, Monohydrochloride, (4s-(4alpha,4aalpha,5aalpha,12aalpha))-
56. Mls002548863
57. Spectrum1500414
58. Fxfm-244
59. Chembl1200881
60. Chembl4576719
61. Dtxsid8044545
62. Hms1568p12
63. Pharmakon1600-01500414
64. Bcp06597
65. Tox21_111250
66. Tox21_113183
67. Tox21_301590
68. Ccg-40107
69. Nsc757120
70. S4226
71. Minocycline Hydrochloride [mi]
72. Minocycline Hydrochloride, Crystalline
73. Akos015951312
74. Minocycline Hydrochloride (jp17/usp)
75. Tox21_111250_1
76. Cs-1256
77. Minocycline Hydrochloride [jan]
78. Nc00460
79. Nsc-757120
80. Minocycline Hydrochloride [mart.]
81. Minocycline Hydrochloride [vandf]
82. Ncgc00178854-03
83. Ncgc00255988-01
84. Ac-22362
85. As-75306
86. Hy-17412
87. Minocycline Hydrochloride [usp-rs]
88. Minocycline Hydrochloride [who-dd]
89. Smr001906766
90. M2288
91. D00850
92. Minocycline Hydrochloride [orange Book]
93. Minocycline Hydrochloride [usp Monograph]
94. 614m987
95. Sr-01000075625
96. Q-201407
97. Sr-01000075625-1
98. Q27104777
99. Minocycline Hydrochloride, Antibiotic For Culture Media Use Only
100. Minocycline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
101. Minocycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
102. Minocycline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
103. (4s,12as,4as,5ar)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide Hydrochloride
104. (4s,4as,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamidehydrochloride
105. 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, Monohydrochloride, (4s-(4.alpha.,4a.alpha.,5a.alpha.,12a.alpha.))-
| Molecular Weight | 493.9 g/mol |
|---|---|
| Molecular Formula | C23H28ClN3O7 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 493.1615779 g/mol |
| Monoisotopic Mass | 493.1615779 g/mol |
| Topological Polar Surface Area | 165 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 971 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 10 | |
|---|---|
| Drug Name | Arestin |
| PubMed Health | Minocycline |
| Drug Classes | Amebicide, Intestinal, Antiacne, Antiacne Antibacterial, Antibiotic, Antiprotozoal, Tetracycline |
| Drug Label | ARESTIN (minocycline hydrochloride) Microspheres is a subgingival sustained-release product containing the antibiotic minocycline hydrochloride incorporated into a bioresorbable polymer, Poly (glycolide-co-dl-lactide) or PGLA, for professional subg... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Powder, extended release |
| Route | Dental |
| Strength | eq 1mg base |
| Market Status | Prescription |
| Company | Orapharma |
| 2 of 10 | |
|---|---|
| Drug Name | Dynacin |
| Drug Label | Minocycline hydrochloride, is a semisynthetic derivative of tetracycline, 4,7-Bis(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1, 11-dioxo-2naphthacenecarboxamide monohydrochloride. Its structural formula is:C23H27N3O7... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | eq 100mg base; eq 75mg base |
| Market Status | Prescription |
| Company | Cnty Line Pharms |
| 3 of 10 | |
|---|---|
| Drug Name | Minocin |
| PubMed Health | Minocycline, Regular Release (By mouth) |
| Drug Classes | Amebicide, Intestinal, Antiacne, Antibiotic, Antiprotozoal |
| Drug Label | MINOCIN minocycline hydrochloride, is a semisynthetic derivative of tetracycline, 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride.Its structural formula is:C23H27N... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | eq 100mg base; eq 50mg base; eq 100mg base/vial |
| Market Status | Prescription |
| Company | Rempex Pharms; Precision Dermat |
| 4 of 10 | |
|---|---|
| Drug Name | Minocycline hydrochloride |
| Drug Label | To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride capsules and other antibacterial drugs, minocycline hydrochloride capsules should be used only to treat or prevent infections that are pr... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Tablet, extended release; Tablet; Capsule |
| Route | oral; Oral |
| Strength | 65mg; 115mg; eq 100mg base; eq 50mg base; eq 105mg base; eq 65mg base; eq 115mg base; eq 75mg base; eq 90mg base; eq 80mg base; 55mg; eq 45mg base; eq 55mg base; eq 135mg base |
| Market Status | Tentative Approval; Prescription |
| Company | Mylan Pharms; Ranbaxy; Teva; Mylan Labs; Sun Pharm Inds; Aurobindo Pharma; Lupin; Barr Labs; Sandoz; Par Pharm; Watson Labs; Ranbaxy Labs; Dr Reddys Labs; Impax Labs |
| 5 of 10 | |
|---|---|
| Drug Name | Solodyn |
| PubMed Health | Minocycline |
| Drug Classes | Amebicide, Intestinal, Antiacne, Antiacne Antibacterial, Antibiotic, Antiprotozoal, Tetracycline |
| Drug Label | Minocycline hydrochloride, a semi synthetic derivative of tetracycline, is [4S-(4,4a,5a,12a)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide mono hydrochloride. The structura... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 105mg base; eq 65mg base; eq 115mg base; eq 80mg base; eq 55mg base |
| Market Status | Prescription |
| Company | Medicis |
| 6 of 10 | |
|---|---|
| Drug Name | Arestin |
| PubMed Health | Minocycline |
| Drug Classes | Amebicide, Intestinal, Antiacne, Antiacne Antibacterial, Antibiotic, Antiprotozoal, Tetracycline |
| Drug Label | ARESTIN (minocycline hydrochloride) Microspheres is a subgingival sustained-release product containing the antibiotic minocycline hydrochloride incorporated into a bioresorbable polymer, Poly (glycolide-co-dl-lactide) or PGLA, for professional subg... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Powder, extended release |
| Route | Dental |
| Strength | eq 1mg base |
| Market Status | Prescription |
| Company | Orapharma |
| 7 of 10 | |
|---|---|
| Drug Name | Dynacin |
| Drug Label | Minocycline hydrochloride, is a semisynthetic derivative of tetracycline, 4,7-Bis(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1, 11-dioxo-2naphthacenecarboxamide monohydrochloride. Its structural formula is:C23H27N3O7... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | eq 100mg base; eq 75mg base |
| Market Status | Prescription |
| Company | Cnty Line Pharms |
| 8 of 10 | |
|---|---|
| Drug Name | Minocin |
| PubMed Health | Minocycline, Regular Release (By mouth) |
| Drug Classes | Amebicide, Intestinal, Antiacne, Antibiotic, Antiprotozoal |
| Drug Label | MINOCIN minocycline hydrochloride, is a semisynthetic derivative of tetracycline, 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride.Its structural formula is:C23H27N... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | eq 100mg base; eq 50mg base; eq 100mg base/vial |
| Market Status | Prescription |
| Company | Rempex Pharms; Precision Dermat |
| 9 of 10 | |
|---|---|
| Drug Name | Minocycline hydrochloride |
| Drug Label | To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride capsules and other antibacterial drugs, minocycline hydrochloride capsules should be used only to treat or prevent infections that are pr... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Tablet, extended release; Tablet; Capsule |
| Route | oral; Oral |
| Strength | 65mg; 115mg; eq 100mg base; eq 50mg base; eq 105mg base; eq 65mg base; eq 115mg base; eq 75mg base; eq 90mg base; eq 80mg base; 55mg; eq 45mg base; eq 55mg base; eq 135mg base |
| Market Status | Tentative Approval; Prescription |
| Company | Mylan Pharms; Ranbaxy; Teva; Mylan Labs; Sun Pharm Inds; Aurobindo Pharma; Lupin; Barr Labs; Sandoz; Par Pharm; Watson Labs; Ranbaxy Labs; Dr Reddys Labs; Impax Labs |
| 10 of 10 | |
|---|---|
| Drug Name | Solodyn |
| PubMed Health | Minocycline |
| Drug Classes | Amebicide, Intestinal, Antiacne, Antiacne Antibacterial, Antibiotic, Antiprotozoal, Tetracycline |
| Drug Label | Minocycline hydrochloride, a semi synthetic derivative of tetracycline, is [4S-(4,4a,5a,12a)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide mono hydrochloride. The structura... |
| Active Ingredient | Minocycline hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | eq 105mg base; eq 65mg base; eq 115mg base; eq 80mg base; eq 55mg base |
| Market Status | Prescription |
| Company | Medicis |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - EQ 100MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 100MG BASE/VIAL
USFDA APPLICATION NUMBER - 50444
DOSAGE - CAPSULE;ORAL - EQ 100MG BASE
USFDA APPLICATION NUMBER - 50649
DOSAGE - CAPSULE;ORAL - EQ 50MG BASE
USFDA APPLICATION NUMBER - 50649
DOSAGE - CAPSULE;ORAL - EQ 75MG BASE **Federa...DOSAGE - CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50649
DOSAGE - POWDER, EXTENDED RELEASE;DENTAL - EQ...DOSAGE - POWDER, EXTENDED RELEASE;DENTAL - EQ 1MG BASE
USFDA APPLICATION NUMBER - 50781
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 1...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE
USFDA APPLICATION NUMBER - 50808
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 1...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE
USFDA APPLICATION NUMBER - 50808
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 1...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50808
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 4...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50808
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE
USFDA APPLICATION NUMBER - 50808
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 6...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE
USFDA APPLICATION NUMBER - 50808
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 8...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE
USFDA APPLICATION NUMBER - 50808
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 9...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50808
Related Excipient Companies
Minakem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Minbiotech
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Thickeners and Stabilizers
Lubricants & Glidants
Solubilizers
Direct Compression
Granulation
Film Formers & Plasticizers
Disintegrants & Superdisintegrants
Topical
Co-Processed Excipients
Parenteral
Taste Masking
Empty Capsules
Emulsifying Agents
Chewable & Orodispersible Aids
API Stability Enhancers
Rheology Modifiers
Surfactant & Foaming Agents
Coloring Agents
Vegetarian Capsules
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory FDF Prices
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 75MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : RX
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
RX/OTC/DISCN : Class C
TEOFARMA Srl
Dosage Form :
Dosage Strength : 16 Cps 50 Mg
Price Per Pack (Euro) : 6.73
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
100
PharmaCompass offers a list of Minocycline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Minocycline Hydrochloride manufacturer or Minocycline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Minocycline Hydrochloride manufacturer or Minocycline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Minocycline Hydrochloride API Price utilized in the formulation of products. Minocycline Hydrochloride API Price is not always fixed or binding as the Minocycline Hydrochloride Price is obtained through a variety of data sources. The Minocycline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Aknosan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aknosan, including repackagers and relabelers. The FDA regulates Aknosan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aknosan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aknosan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aknosan supplier is an individual or a company that provides Aknosan active pharmaceutical ingredient (API) or Aknosan finished formulations upon request. The Aknosan suppliers may include Aknosan API manufacturers, exporters, distributors and traders.
click here to find a list of Aknosan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aknosan DMF (Drug Master File) is a document detailing the whole manufacturing process of Aknosan active pharmaceutical ingredient (API) in detail. Different forms of Aknosan DMFs exist exist since differing nations have different regulations, such as Aknosan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aknosan DMF submitted to regulatory agencies in the US is known as a USDMF. Aknosan USDMF includes data on Aknosan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aknosan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aknosan suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Aknosan Drug Master File in Japan (Aknosan JDMF) empowers Aknosan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Aknosan JDMF during the approval evaluation for pharmaceutical products. At the time of Aknosan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Aknosan suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aknosan Drug Master File in Korea (Aknosan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aknosan. The MFDS reviews the Aknosan KDMF as part of the drug registration process and uses the information provided in the Aknosan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aknosan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aknosan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aknosan suppliers with KDMF on PharmaCompass.
A Aknosan CEP of the European Pharmacopoeia monograph is often referred to as a Aknosan Certificate of Suitability (COS). The purpose of a Aknosan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Aknosan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Aknosan to their clients by showing that a Aknosan CEP has been issued for it. The manufacturer submits a Aknosan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Aknosan CEP holder for the record. Additionally, the data presented in the Aknosan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Aknosan DMF.
A Aknosan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Aknosan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Aknosan suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aknosan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aknosan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aknosan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aknosan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aknosan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aknosan suppliers with NDC on PharmaCompass.
Aknosan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aknosan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aknosan GMP manufacturer or Aknosan GMP API supplier for your needs.
A Aknosan CoA (Certificate of Analysis) is a formal document that attests to Aknosan's compliance with Aknosan specifications and serves as a tool for batch-level quality control.
Aknosan CoA mostly includes findings from lab analyses of a specific batch. For each Aknosan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aknosan may be tested according to a variety of international standards, such as European Pharmacopoeia (Aknosan EP), Aknosan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aknosan USP).
